Today's announcement will set the tone for how the Trump administration wants to work with private Medicare insurers.
A four-month FDA delay prompted a cash-strapped biotech company to shutter. The White House’s proposed NIH cuts are drawing ...
A small biotech was forced to being winding down its operations after the FDA abruptly postponed a key meeting for four ...
Neurocrine Biosciences is buying Soleno Therapeutics for $2.9 billion, picking up an approved medicine for a rare disease ...
STAT’s Chelsea Cirruzzo and John Wilkerson have the rundown on the proposal, as well as how likely Congress is to go along ...
In February, a small biotech company reached a breakthrough with the FDA, agreeing to a clinical trial plan. The problem: The ...
UnitedHealth Group is rapidly deploying artificial intelligence tools across its operations. What does it mean for patients?
The U.S. health care system is often described as strained or overwhelmed. From where I am sitting, it is broken. The ...
The Medical Foods and Formulas Access Act of 2025, introduced in the House on Oct. 3, 2025, would expand access to medically ...
Why do RFK Jr. and other health influencers embrace unproven peptides while calling for more research into well-studied ...
The CDC has “temporarily paused” diagnostic testing for rabies and pox viruses, according to a recent update to the agency ...
The White House is asking Congress to cut $5 billion from the National Institutes of Health and downsize the number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results